Posted by & filed under Financial Planning, Growth & Valuation, Market Analysis.

Description: Pershing Square’s Bill Ackman wasn’t able to convince Wall Street once and for all whether embattled drugmaker Valeant Pharmaceuticals can recover from its woes or will continue heading south.


Date: Oct 30, 2015


Questions for discussion:

  • What does the article say about Bill Ackman’s strategic thinking?
  • Do you agree?

Leave a Reply

Your email address will not be published. Required fields are marked *